Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Colorectal Neoplasms 3Pancreatic Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Irinotecan 2tivozanib 1repotrectinib 1belinostat 1atezolizumab 1Topotecan 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Leucovorin 1IFL protocol 1Fluorouracil 1Etoposide 1Cisplatin 1Biopsy 1BAY 1895344 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Neuroendocrine × IFL protocol × 30 days × Clear all
NCT07595913 2026-05-19

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3 Not yet recruiting
240 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡